TrialScientific reports2024

Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer.

Poorna Anandavadivelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.